What is AMREP's operating income?

AMREP's total operating income in 2026 was $12.39 million, based on the following breakdown: Total Gross Profit: $21.42 million Total Operating Expenses: $9.03 million

AMREP (AXR) Financials

$25.12 -0.29 (-1.12%)

Closing price 07/24/2026 03:59 PM Eastern

Extended Trading

$23.75 -1.38 (-5.47%)

As of 07/24/2026 04:51 PM Eastern

Compare

Annual Income Statements for AMREP

This table shows AMREP's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	4/30/2016	4/30/2017	4/30/2018	4/30/2019	4/30/2020	4/30/2021	4/30/2022	4/30/2023	4/30/2024	4/30/2025	4/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-10	-0.02	0.24	-4.92	-5.90	7.39	16	22	6.69	13	10
Consolidated Net Income / (Loss)	-10	-0.02	0.24	1.53	-5.90	7.39	16	22	6.69	13	10
Net Income / (Loss) Continuing Operations	-10	-0.02	-2.56	-2.47	-5.90	7.39	16	22	6.69	13	10
Total Pre-Tax Income	-15	0.98	-2.84	-3.17	-7.63	10	22	7.64	8.43	14	14
Total Operating Income	-15	0.98	-2.84	-6.45	-7.96	9.05	21	5.83	7.60	12	12
Total Gross Profit	42	42	2.87	15	5.00	14	27	19	14	19	21
Total Revenue	42	42	8.93	26	19	40	59	49	51	50	53
Operating Revenue	40	40	8.44	26	19	40	59	49	51	50	53
Total Cost of Revenue	0.00	0.00	6.06	11	14	26	32	30	37	30	31
Operating Cost of Revenue	-	-	6.06	11	14	26	32	30	37	30	31
Total Operating Expenses	57	41	5.71	21	13	5.42	5.35	13	6.87	7.28	9.03
Selling, General & Admin Expense	8.49	5.03	4.05	20	13	5.42	5.35	5.47	6.87	7.28	9.03
Total Other Income / (Expense), net	0.00	0.00	0.00	-3.17	0.33	0.99	0.26	1.81	0.82	1.62	1.73
Interest Expense	-	-	-	-0.05	-0.33	0.04	-0.00	-0.01	-0.82	-1.62	-1.73
Other Income / (Expense), net	-	-	-	3.23	0.00	1.03	0.26	1.80	0.00	-0.00	0.00
Income Tax Expense	-5.21	1.00	-0.28	-0.71	-1.72	2.64	5.70	-14	1.74	1.01	3.84
Basic Earnings per Share	($1.27)	$0.00	$0.03	$0.19	($0.73)	$0.95	$2.21	$4.13	$1.26	$2.39	$1.93
Weighted Average Basic Shares Outstanding	8.04M	8.05M	8.07M	8.10M	8.13M	7.74M	7.17M	5.28M	5.30M	5.32M	5.34M
Diluted Earnings per Share	($1.27)	$0.00	$0.03	$0.19	($0.73)	$0.95	$2.21	$4.11	$1.25	$2.37	$1.91
Weighted Average Diluted Shares Outstanding	8.06M	8.08M	8.10M	8.15M	8.13M	7.77M	7.19M	5.31M	5.35M	5.37M	5.39M
Weighted Average Basic & Diluted Shares Outstanding	8.04M	8.09M	8.13M	8.14M	8.14M	7.32M	5.25M	5.25M	5.29M	5.31M	5.32M

This table shows AMREP's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
Net Income / (Loss) Attributable to Common Shareholders	1.11	0.09	4.14	4.06	4.04	0.72	3.89	4.69	1.20	3.15	1.25
Consolidated Net Income / (Loss)	1.11	0.09	4.14	4.06	4.04	0.72	3.89	4.69	1.20	3.15	1.25
Net Income / (Loss) Continuing Operations	1.11	0.09	4.14	4.06	4.04	0.72	3.89	4.69	1.20	3.15	1.25
Total Pre-Tax Income	1.21	0.11	5.03	5.27	3.72	0.84	3.89	6.60	1.58	3.40	2.55
Total Operating Income	1.05	-0.15	4.68	4.99	3.14	0.43	3.54	6.15	1.12	3.01	2.12
Total Gross Profit	2.60	1.75	6.53	6.62	4.97	2.31	5.49	7.99	3.08	5.94	4.41
Total Revenue	8.85	13	20	19	12	7.52	11	18	9.40	15	11
Operating Revenue	8.85	13	20	19	12	7.52	11	18	9.40	15	11
Total Cost of Revenue	6.26	11	13	12	6.94	5.21	5.69	9.86	6.32	8.64	6.61
Operating Cost of Revenue	6.26	11	13	12	6.94	5.21	5.69	9.86	6.32	8.64	6.61
Total Operating Expenses	1.55	1.90	1.85	1.63	1.83	1.88	1.95	1.85	1.96	2.93	2.29
Selling, General & Admin Expense	1.55	1.90	1.85	1.63	1.83	1.88	1.95	1.85	1.96	2.93	2.29
Total Other Income / (Expense), net	0.16	0.26	0.35	0.28	0.58	0.41	0.35	0.46	0.46	0.39	0.43
Interest Expense	-0.16	-0.26	-0.35	-0.28	-0.58	-0.41	-0.36	-0.46	-0.46	-0.39	-0.43
Income Tax Expense	0.11	0.02	0.88	1.21	-0.32	0.13	-0.00	1.91	0.38	0.25	1.30
Basic Earnings per Share	$0.21	$0.02	$0.78	$0.77	$0.76	$0.13	$0.73	$0.88	$0.22	$0.59	$0.24
Weighted Average Basic Shares Outstanding	5.30M	5.30M	5.30M	5.31M	5.32M	5.32M	5.32M	5.33M	5.34M	5.34M	5.34M
Diluted Earnings per Share	$0.21	$0.02	$0.77	$0.76	$0.75	$0.13	$0.73	$0.87	$0.22	$0.58	$0.24
Weighted Average Diluted Shares Outstanding	5.34M	5.35M	5.35M	5.35M	5.37M	5.38M	5.37M	5.38M	5.39M	5.39M	5.39M
Weighted Average Basic & Diluted Shares Outstanding	-	5.27M	5.29M	5.29M	5.29M	5.29M	5.31M	5.31M	5.31M	5.31M	5.32M

This table details how cash moves in and out of AMREP's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	4/30/2016	4/30/2017	4/30/2018	4/30/2019	4/30/2020	4/30/2021	4/30/2022	4/30/2023	4/30/2024	4/30/2025	4/30/2026
Net Change in Cash & Equivalents	2.51	-2.75	2.23	0.20	3.27	7.30	-9.08	4.27	10	9.68	13
Net Cash From Operating Activities	3.47	10	0.53	0.59	0.77	13	15	6.39	11	10	13
Net Cash From Continuing Operating Activities	3.47	10	-2.21	-2.04	0.77	13	15	6.39	11	10	13
Net Income / (Loss) Continuing Operations	-10	-0.02	-2.56	-2.47	-5.90	7.39	16	22	6.69	13	10
Consolidated Net Income / (Loss)	-10	-0.02	0.24	1.53	-5.90	7.39	16	22	6.69	13	10
Depreciation Expense	2.98	1.40	0.51	0.61	0.54	0.55	0.23	0.06	0.15	0.18	0.31
Non-Cash Adjustments To Reconcile Net Income	18	7.53	-1.88	1.99	11	2.18	-7.61	4.43	1.88	-2.67	-0.65
Changes in Operating Assets and Liabilities, net	-6.93	1.53	1.72	-2.19	-5.10	2.43	6.92	-20	2.00	0.02	2.93
Net Cash From Investing Activities	2.80	-0.25	-0.14	0.15	-0.01	-0.01	-1.20	-0.13	-0.46	-0.55	-0.10
Net Cash From Continuing Investing Activities	2.80	-0.25	-0.05	0.08	-0.01	-0.01	-1.20	-0.13	-0.46	-0.55	-0.10
Purchase of Property, Plant & Equipment	-0.80	-0.25	-0.05	-0.01	-0.01	-0.01	-1.29	-0.13	-0.46	-0.58	-0.10
Sale of Property, Plant & Equipment	1.60	-	-	-	-	-	-	-	0.00	0.03	0.00
Net Cash From Financing Activities	-3.76	-13	1.84	-0.55	2.51	-5.31	-23	-1.99	-0.01	-0.01	-0.01
Net Cash From Continuing Financing Activities	-3.76	-13	1.84	-0.55	2.51	-5.31	-23	-1.99	-0.01	-0.01	-0.01
Repayment of Debt	-5.71	-13	-0.05	-3.67	-2.15	-6.80	-8.31	-2.04	-0.01	-0.01	-0.01
Cash Income Taxes Paid	0.91	-0.14	0.01	-0.25	-0.15	0.15	0.00	0.13	0.31	0.32	0.50

This table details how cash moves in and out of AMREP's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
Net Change in Cash & Equivalents	-5.06	1.29	12	11	-0.27	-3.24	2.53	9.50	-4.31	5.38	2.20
Net Cash From Operating Activities	0.04	1.51	7.33	11	-0.18	-3.24	2.97	9.53	-4.25	5.40	2.20
Net Cash From Continuing Operating Activities	0.04	1.51	7.33	11	-0.18	-3.24	2.97	9.53	-4.25	5.40	2.20
Net Income / (Loss) Continuing Operations	1.11	0.09	4.14	4.06	4.04	0.72	3.89	4.69	1.20	3.15	1.25
Consolidated Net Income / (Loss)	1.11	0.09	4.14	4.06	4.04	0.72	3.89	4.69	1.20	3.15	1.25
Depreciation Expense	0.04	0.03	0.04	0.05	0.05	0.03	0.05	0.08	0.08	0.09	0.06
Non-Cash Adjustments To Reconcile Net Income	-0.57	0.18	2.83	5.30	-2.93	-3.10	-1.94	1.04	-4.14	1.69	0.75
Changes in Operating Assets and Liabilities, net	-0.54	1.21	0.31	1.28	-1.34	-0.88	0.97	3.72	-1.40	0.47	0.14
Net Cash From Investing Activities	-5.09	-0.22	4.90	-0.03	-0.09	0.00	-0.44	-0.02	-0.06	-0.02	-0.00
Net Cash From Continuing Investing Activities	-5.09	-0.22	4.90	-0.03	-0.09	0.00	-0.44	-0.02	-0.06	-0.02	-0.00
Purchase of Property, Plant & Equipment	-0.10	-0.18	-0.15	-0.03	-0.09	-0.03	-0.44	-0.02	-0.06	-0.02	-0.00
Net Cash From Financing Activities	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Net Cash From Continuing Financing Activities	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Repayment of Debt	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Cash Income Taxes Paid	-	-	-	0.13	0.03	-	-	0.00	-	-	0.50

This table presents AMREP's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	4/30/2016	4/30/2017	4/30/2018	4/30/2019	4/30/2020	4/30/2021	4/30/2022	4/30/2023	4/30/2024	4/30/2025	4/30/2026
Total Assets	121	107	106	101	97	97	95	116	123	134	145
Total Current Assets	22	18	26	13	18	25	83	86	96	106	119
Cash & Equivalents	15	12	11	13	18	25	16	20	30	39	52
Inventories, net	-	-	-	-	-	-	67	66	66	67	67
Plant, Property, & Equipment, net	12	11	0.00	0.00	0.00	0.00	9.02	14	13	15	16
Total Noncurrent Assets	87	78	80	87	79	73	2.84	16	15	12	9.83
Noncurrent Deferred & Refundable Income Taxes	11	9.52	2.97	4.54	6.08	2.75	0.96	12	11	8.97	5.77
Other Noncurrent Operating Assets	75	68	77	83	73	70	1.88	3.25	3.54	3.39	4.05
Total Liabilities & Shareholders' Equity	121	107	106	101	97	97	95	116	123	134	145
Total Liabilities	38	22	19	11	12	8.48	12	4.90	4.78	3.82	4.04
Total Current Liabilities	9.01	7.04	8.07	2.96	3.13	4.46	6.08	4.85	4.75	3.79	4.02
Accounts Payable	8.45	7.04	2.77	2.96	3.13	4.46	6.08	4.85	4.75	3.79	4.02
Total Noncurrent Liabilities	29	15	11	7.72	8.90	4.02	5.68	0.04	0.04	0.03	0.02
Long-Term Debt	12	-	1.84	1.32	3.89	3.45	2.03	0.04	0.04	0.03	0.02
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	-	-	-	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	83	85	87	90	85	89	83	111	118	130	141
Total Preferred & Common Equity	83	85	87	90	85	89	83	111	118	130	141
Total Common Equity	83	85	87	90	85	89	83	111	118	130	141
Common Stock	51	52	52	52	52	46	33	33	34	34	34
Retained Earnings	47	47	48	49	43	48	55	77	83	96	106

This table presents AMREP's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	7/31/2023	10/31/2023	1/31/2024	7/31/2024	10/31/2024	1/31/2025	7/31/2025	10/31/2025	1/31/2026
Total Assets	117	118	119	127	129	129	141	140	144
Total Current Assets	85	86	91	101	103	102	114	113	117
Cash & Equivalents	22	17	18	40	40	37	49	45	50
Inventories, net	63	64	68	60	63	65	65	69	67
Current Deferred & Refundable Income Taxes	-	-	-	-	-	-	0.08	0.00	0.00
Plant, Property, & Equipment, net	17	17	13	13	13	14	16	16	17
Total Noncurrent Assets	14	15	15	13	13	12	11	11	11
Noncurrent Deferred & Refundable Income Taxes	12	12	12	10	9.37	9.14	7.29	7.03	6.96
Other Noncurrent Operating Assets	2.56	2.84	2.83	3.30	3.31	3.26	3.65	3.54	3.60
Total Liabilities & Shareholders' Equity	117	118	119	127	129	129	141	140	144
Total Liabilities	4.55	4.22	5.21	4.83	4.01	2.96	5.93	4.11	4.57
Total Current Liabilities	4.51	4.18	5.17	4.80	3.97	2.93	5.91	4.08	4.54
Accounts Payable	4.46	3.76	4.98	4.44	3.41	2.93	5.91	4.05	4.53
Current Deferred & Payable Income Tax Liabilities	0.05	0.42	0.19	0.36	0.56	-	-	0.03	0.01
Total Noncurrent Liabilities	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.02	0.02
Long-Term Debt	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.02	0.02
Commitments & Contingencies	-	-	-	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	112	114	114	122	125	126	135	136	139
Total Preferred & Common Equity	112	114	114	122	125	126	135	136	139
Total Common Equity	112	114	114	122	125	126	135	136	139
Common Stock	33	33	33	34	34	34	34	34	34
Retained Earnings	78	79	79	87	91	92	101	102	105

This table displays calculated financial ratios and metrics derived from AMREP's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	4/30/2016	4/30/2017	4/30/2018	4/30/2019	4/30/2020	4/30/2021	4/30/2022	4/30/2023	4/30/2024	4/30/2025	4/30/2026
DEI Shares Outstanding	8,059,454.00	8,077,954.00	8,098,704.00	8,127,904.00	8,136,904.00	7,323,370.00	7,336,370.00	5,254,909.00	-	5,287,449.00	5,305,199.00
DEI Adjusted Shares Outstanding	8,059,454.00	8,077,954.00	8,098,704.00	8,127,904.00	8,136,904.00	7,323,370.00	7,336,370.00	5,254,909.00	-	5,287,449.00	5,305,199.00
DEI Earnings Per Adjusted Shares Outstanding	-1.27	0.00	0.03	-0.61	-0.73	1.01	2.16	4.15	-	2.40	1.94
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.32%	1.69%	-78.93%	185.74%	-26.36%	113.33%	47.06%	-17.39%	5.53%	-3.26%	6.34%
EBITDA Growth	-408.08%	119.09%	-198.15%	-11.14%	-183.62%	245.28%	104.65%	-64.82%	0.71%	58.46%	3.44%
EBIT Growth	-170.03%	106.36%	-389.51%	-13.44%	-146.79%	226.59%	114.03%	-64.60%	-0.41%	59.21%	2.39%
NOPAT Growth	-170.03%	99.86%	-13,167.33%	-126.87%	-23.40%	219.62%	135.11%	6.11%	-63.69%	85.82%	-19.54%
Net Income Growth	-190.32%	99.85%	1,686.67%	541.60%	-486.58%	225.22%	114.58%	37.37%	-69.30%	90.07%	-19.09%
EPS Growth	-188.81%	100.00%	0.00%	533.33%	-484.21%	230.14%	132.63%	85.97%	-69.59%	89.60%	-19.41%
Operating Cash Flow Growth	-65.20%	201.04%	-94.91%	11.49%	29.22%	1,548.24%	22.74%	-58.72%	67.69%	-4.41%	25.74%
Free Cash Flow Firm Growth	-41.89%	37.74%	-74.81%	-751.97%	109.68%	680.00%	36.15%	-130.79%	299.28%	14.90%	13.69%
Invested Capital Growth	-17.09%	-10.09%	-5.55%	12.94%	-8.82%	-4.91%	2.73%	30.10%	-2.71%	2.41%	-1.85%
Revenue Q/Q Growth	-2.85%	0.59%	-77.57%	300.63%	-37.98%	-3.05%	49.10%	-16.75%	0.00%	-14.40%	-0.29%
EBITDA Q/Q Growth	-156.02%	128.33%	-161.76%	68.23%	-21.06%	285.01%	104.65%	-61.62%	0.00%	-8.45%	-9.96%
EBIT Q/Q Growth	-96.27%	109.57%	-214.31%	60.28%	-17.98%	333.71%	114.03%	-61.85%	0.00%	-8.62%	-10.27%
NOPAT Q/Q Growth	-96.27%	99.79%	3.21%	20.56%	-17.98%	278.03%	135.11%	-42.39%	0.00%	-2.93%	-21.83%
Net Income Q/Q Growth	-480.50%	99.78%	111.58%	5.53%	-100.17%	69.46%	114.58%	-30.89%	0.00%	-1.94%	-20.45%
EPS Q/Q Growth	-496.88%	100.00%	112.00%	5.56%	-942.86%	206.45%	132.63%	-24.86%	0.00%	-1.66%	-20.42%
Operating Cash Flow Q/Q Growth	277.16%	-15.28%	-87.84%	138.74%	-56.73%	726.28%	22.74%	-49.49%	-4.19%	-29.88%	-5.63%
Free Cash Flow Firm Q/Q Growth	78.20%	-31.46%	7.33%	-19.84%	123.24%	91.97%	-82.79%	93.56%	0.00%	-27.76%	-4.60%
Invested Capital Q/Q Growth	-13.46%	-2.29%	-2.53%	2.11%	-7.96%	-8.29%	0.00%	-4.96%	0.00%	1.63%	-0.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	32.10%	57.76%	26.61%	36.11%	45.24%	38.83%	28.17%	39.01%	40.53%
EBITDA Margin	-29.90%	5.61%	-26.15%	-10.17%	-39.17%	26.67%	37.12%	15.81%	15.09%	24.72%	24.04%
Operating Margin	-37.05%	2.32%	-31.85%	-25.29%	-42.37%	22.58%	36.15%	11.98%	14.80%	24.36%	23.45%
EBIT Margin	-37.05%	2.32%	-31.85%	-12.64%	-42.37%	25.14%	36.60%	15.68%	14.80%	24.36%	23.45%
Profit (Net Income) Margin	-24.54%	-0.04%	2.67%	5.99%	-31.43%	18.45%	26.92%	44.77%	13.02%	25.59%	19.47%
Tax Burden Percent	66.24%	-1.53%	-8.37%	-48.12%	77.42%	73.66%	73.55%	285.17%	79.41%	92.65%	72.83%
Interest Burden Percent	100.00%	100.00%	100.00%	98.39%	95.80%	99.60%	100.01%	100.10%	110.83%	113.40%	113.99%
Effective Tax Rate	0.00%	101.53%	0.00%	0.00%	0.00%	26.34%	26.45%	-185.17%	20.59%	7.35%	27.17%
Return on Invested Capital (ROIC)	-12.06%	-0.02%	-2.80%	-6.15%	-7.48%	9.62%	22.89%	20.83%	6.78%	12.54%	10.10%
ROIC Less NNEP Spread (ROIC-NNEP)	26.35%	-0.02%	-17.67%	-46.28%	-4.89%	5.46%	21.79%	-9.10%	4.22%	8.20%	7.35%
Return on Net Nonoperating Assets (RNNOA)	0.45%	0.00%	3.08%	7.87%	0.72%	-1.10%	-4.45%	1.62%	-0.94%	-2.28%	-2.50%
Return on Equity (ROE)	-11.61%	-0.02%	0.28%	1.73%	-6.77%	8.52%	18.44%	22.45%	5.84%	10.25%	7.60%
Cash Return on Invested Capital (CROIC)	6.63%	10.61%	2.90%	-18.31%	1.75%	14.66%	20.19%	-5.33%	9.53%	10.16%	11.96%
Operating Return on Assets (OROA)	-11.90%	0.86%	-2.67%	-3.12%	-8.07%	10.38%	22.43%	7.24%	6.37%	9.43%	8.90%
Return on Assets (ROA)	-7.88%	-0.01%	0.22%	1.48%	-5.99%	7.62%	16.50%	20.67%	5.60%	9.91%	7.39%
Return on Common Equity (ROCE)	-11.61%	-0.02%	0.28%	1.73%	-6.77%	8.52%	18.44%	22.45%	5.84%	10.25%	7.60%
Return on Equity Simple (ROE_SIMPLE)	-12.34%	-0.02%	0.27%	1.70%	-6.97%	8.32%	19.07%	19.63%	5.67%	9.78%	0.00%
Net Operating Profit after Tax (NOPAT)	-11	-0.02	-1.99	-4.52	-5.57	6.66	16	17	6.04	11	9.03
NOPAT Margin	-25.93%	-0.04%	-22.29%	-17.70%	-29.66%	16.63%	26.59%	34.16%	11.75%	22.57%	17.08%
Net Nonoperating Expense Percent (NNEP)	-38.41%	0.00%	14.87%	40.14%	-2.60%	4.16%	1.10%	29.92%	2.56%	4.34%	2.75%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	8.63%	6.41%
Cost of Revenue to Revenue	0.00%	0.00%	67.90%	42.24%	73.39%	63.89%	54.76%	61.17%	71.83%	60.99%	59.47%
SG&A Expenses to Revenue	20.37%	11.88%	45.39%	76.71%	68.98%	13.53%	9.09%	11.24%	13.38%	14.65%	17.08%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	137.05%	97.68%	63.95%	83.04%	68.98%	13.53%	9.09%	26.85%	13.38%	14.65%	17.08%
Earnings before Interest and Taxes (EBIT)	-15	0.98	-2.84	-3.23	-7.96	10	22	7.63	7.60	12	12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-12	2.38	-2.33	-2.59	-7.36	11	22	7.70	7.75	12	13
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.43	0.57	0.67	0.50	0.47	0.88	1.13	0.66	0.91	0.92	1.04
Price to Tangible Book Value (P/TBV)	0.43	0.57	0.67	0.50	0.47	0.88	1.13	0.66	0.91	0.92	1.04
Price to Revenue (P/Rev)	0.86	1.15	6.58	1.78	2.10	1.96	1.60	1.50	2.08	2.40	2.77
Price to Earnings (P/E)	0.00	0.00	246.70	0.00	0.00	10.60	5.95	3.35	15.98	9.38	14.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.41%	0.00%	0.00%	9.43%	16.81%	29.83%	6.26%	10.66%	7.04%
Enterprise Value to Invested Capital (EV/IC)	0.42	0.50	0.72	0.43	0.36	0.84	1.16	0.59	0.87	0.88	1.06
Enterprise Value to Revenue (EV/Rev)	0.82	0.87	5.57	1.31	1.37	1.42	1.37	1.09	1.49	1.61	1.78
Enterprise Value to EBITDA (EV/EBITDA)	0.00	15.45	0.00	0.00	0.00	5.33	3.69	6.90	9.90	6.50	7.39
Enterprise Value to EBIT (EV/EBIT)	0.00	37.41	0.00	0.00	0.00	5.66	3.74	6.96	10.09	6.59	7.57
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	8.55	5.15	3.19	12.71	7.11	10.40
Enterprise Value to Operating Cash Flow (EV/OCF)	9.88	3.52	93.61	56.43	33.69	4.52	5.21	8.31	7.16	7.79	7.29
Enterprise Value to Free Cash Flow (EV/FCFF)	5.76	4.49	24.11	0.00	19.80	5.61	5.83	0.00	9.04	8.78	8.78
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.16	0.00	0.02	0.01	0.05	0.04	0.02	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.15	0.00	0.02	0.01	0.05	0.04	0.02	0.00	0.00	0.00	0.00
Financial Leverage	0.02	-0.08	-0.17	-0.17	-0.15	-0.20	-0.20	-0.18	-0.22	-0.28	-0.34
Leverage Ratio	1.47	1.36	1.24	1.17	1.13	1.12	1.12	1.09	1.04	1.03	1.03
Compound Leverage Factor	1.47	1.36	1.24	1.15	1.08	1.11	1.12	1.09	1.16	1.17	1.17
Debt to Total Capital	13.51%	0.00%	2.07%	1.45%	4.39%	3.73%	2.38%	0.04%	0.03%	0.02%	0.01%
Short-Term Debt to Total Capital	0.58%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	12.93%	0.00%	2.07%	1.45%	4.39%	3.73%	2.38%	0.04%	0.03%	0.02%	0.01%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.49%	100.00%	97.93%	98.55%	95.61%	96.27%	97.62%	99.96%	99.97%	99.98%	99.99%
Debt to EBITDA	-1.04	0.00	-0.79	-0.51	-0.53	0.32	0.09	0.01	0.00	0.00	0.00
Net Debt to EBITDA	0.13	0.00	3.86	4.61	1.85	-2.00	-0.63	-2.59	-3.90	-3.21	-4.12
Long-Term Debt to EBITDA	-0.99	0.00	-0.79	-0.51	-0.53	0.32	0.09	0.01	0.00	0.00	0.00
Debt to NOPAT	-1.20	0.00	-0.93	-0.29	-0.70	0.52	0.13	0.00	0.01	0.00	0.00
Net Debt to NOPAT	0.15	0.00	4.53	2.65	2.44	-3.20	-0.87	-1.20	-5.00	-3.52	-5.80
Long-Term Debt to NOPAT	-1.15	0.00	-0.93	-0.29	-0.70	0.52	0.13	0.00	0.01	0.00	0.00
Altman Z-Score	1.16	2.50	2.67	3.50	2.69	7.24	7.97	11.35	15.24	21.35	24.36
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.43	2.59	3.23	4.48	5.60	5.56	13.65	17.65	6.37	28.12	29.60
Quick Ratio	2.42	2.59	1.35	4.48	5.60	5.56	2.59	4.12	6.26	10.42	13.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	5.94	8.18	2.06	-13	1.30	10	14	-4.26	8.48	9.09	11
Operating Cash Flow to CapEx	0.00%	4,191.57%	1,021.15%	7,400.00%	8,500.00%	252,180.00%	1,202.49%	4,877.10%	2,344.42%	1,852.08%	12,625.49%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	253.83	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	315.23	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	315.10	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.32	0.37	0.08	0.25	0.19	0.41	0.61	0.46	0.43	0.39	0.38
Accounts Receivable Turnover	4.50	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.45	0.00	0.46	0.47
Fixed Asset Turnover	3.00	3.71	0.00	0.00	0.00	0.00	0.00	4.28	3.91	3.62	3.40
Accounts Payable Turnover	0.00	0.00	1.24	3.76	4.53	6.75	6.13	5.45	7.69	7.10	8.05
Days Sales Outstanding (DSO)	81.19	58.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	814.37	0.00	799.23	774.05
Days Payable Outstanding (DPO)	0.00	0.00	295.14	97.07	80.61	54.05	59.58	66.98	47.47	51.39	45.33
Cash Conversion Cycle (CCC)	81.19	58.80	-295.14	-97.07	-80.61	-54.05	-59.58	747.39	-47.47	747.84	728.72
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	81	73	69	78	71	68	69	90	88	91	89
Invested Capital Turnover	0.47	0.55	0.13	0.35	0.25	0.58	0.86	0.61	0.58	0.56	0.59
Increase / (Decrease) in Invested Capital	-17	-8.20	-4.05	8.93	-6.87	-3.49	1.85	21	-2.45	2.13	-1.67
Enterprise Value (EV)	34	37	50	33	26	57	81	53	77	80	94
Market Capitalization	36	49	59	45	39	78	94	73	107	119	146
Book Value per Share	$10.28	$10.50	$10.76	$11.05	$10.40	$12.14	$11.34	$21.12	$22.39	$24.58	$26.53
Tangible Book Value per Share	$10.28	$10.50	$10.76	$11.05	$10.40	$12.14	$11.34	$21.12	$22.39	$24.58	$26.53
Total Capital	96	85	89	91	89	92	85	111	118	130	141
Total Debt	13	0.00	1.84	1.32	3.89	3.45	2.03	0.04	0.04	0.03	0.02
Total Long-Term Debt	12	0.00	1.84	1.32	3.89	3.45	2.03	0.04	0.04	0.03	0.02
Net Debt	-1.62	-12	-9.01	-12	-14	-21	-14	-20	-30	-39	-52
Capital Expenditures (CapEx)	-0.80	0.25	0.05	0.01	0.01	0.01	1.29	0.13	0.46	0.55	0.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.13	-0.66	7.15	-2.96	-3.13	-4.46	61	61	-4.75	63	63
Debt-free Net Working Capital (DFNWC)	13	11	18	10	14	20	77	81	25	103	115
Net Working Capital (NWC)	13	11	18	10	14	20	77	81	25	103	115
Net Nonoperating Expense (NNE)	-0.58	0.00	-2.23	-6.04	0.33	-0.73	-0.19	-5.16	-0.65	-1.50	-1.26
Net Nonoperating Obligations (NNO)	-1.62	-12	-18	-12	-14	-21	-14	-21	-30	-39	-52
Total Depreciation and Amortization (D&A)	2.98	1.40	0.51	0.63	0.60	0.61	0.31	0.06	0.15	0.18	0.31
Debt-free, Cash-free Net Working Capital to Revenue	-2.72%	-1.55%	80.08%	-11.62%	-16.64%	-11.13%	103.81%	124.85%	-9.24%	127.34%	118.34%
Debt-free Net Working Capital to Revenue	32.23%	26.33%	201.64%	40.39%	76.54%	50.77%	130.49%	165.93%	49.63%	206.75%	217.36%
Net Working Capital to Revenue	30.90%	26.33%	201.64%	40.39%	76.54%	50.77%	130.49%	165.93%	49.63%	206.75%	217.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.27)	$0.00	$0.03	$0.19	($0.73)	$0.95	$2.21	$4.13	$1.26	$2.39	$1.93
Adjusted Weighted Average Basic Shares Outstanding	8.07M	8.05M	8.07M	8.10M	8.13M	7.74M	7.17M	5.28M	5.30M	5.32M	5.34M
Adjusted Diluted Earnings per Share	($1.27)	$0.00	$0.03	$0.19	($0.73)	$0.95	$2.21	$4.11	$1.25	$2.37	$1.91
Adjusted Weighted Average Diluted Shares Outstanding	8.07M	8.08M	8.10M	8.15M	8.13M	7.77M	7.19M	5.31M	5.35M	5.37M	5.39M
Adjusted Basic & Diluted Earnings per Share	($1.27)	$0.00	$0.03	$0.19	($0.73)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	8.04M	8.09M	8.13M	8.14M	8.14M	7.32M	5.25M	5.25M	5.29M	5.31M	5.32M
Normalized Net Operating Profit after Tax (NOPAT)	-3.52	0.79	-1.99	-4.52	-5.57	6.66	16	4.08	6.04	11	9.03
Normalized NOPAT Margin	-8.45%	1.87%	-22.29%	-17.70%	-29.66%	16.63%	26.59%	8.38%	11.75%	22.57%	17.08%
Pre Tax Income Margin	-37.05%	2.32%	-31.85%	-12.44%	-40.60%	25.04%	36.60%	15.70%	16.40%	27.62%	26.73%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	251.88	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	166.61	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	251.75	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	166.48	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	69.21%	138.09%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from AMREP's official financial filings.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
DEI Shares Outstanding	5,254,909.00	5,271,309.00	5,271,309.00	-	-	-	5,287,449.00	5,305,949.00	5,305,949.00	5,305,199.00	5,305,199.00
DEI Adjusted Shares Outstanding	5,254,909.00	5,271,309.00	5,271,309.00	-	-	-	5,287,449.00	5,305,949.00	5,305,949.00	5,305,199.00	5,305,199.00
DEI Earnings Per Adjusted Shares Outstanding	0.21	0.02	0.79	-	-	-	0.74	0.88	0.23	0.59	0.24
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-45.17%	39.18%	48.90%	85.55%	34.47%	-40.74%	-42.79%	-6.50%	-21.07%	-	-1.36%
EBITDA Growth	-75.59%	-109.09%	3,030.43%	145.26%	191.51%	498.29%	-23.95%	23.49%	-62.37%	-	-39.19%
EBIT Growth	-76.49%	-111.14%	2,574.07%	146.76%	199.14%	391.89%	-24.32%	23.12%	-64.41%	-	-40.10%
NOPAT Growth	-73.51%	97.99%	3,014.15%	192.62%	256.13%	408.00%	-8.14%	13.53%	-75.09%	-	-70.64%
Net Income Growth	-69.40%	-99.44%	1,564.26%	201.93%	264.80%	679.35%	-6.06%	15.45%	-70.31%	-	-67.92%
EPS Growth	-69.12%	-99.36%	1,183.33%	204.00%	257.14%	550.00%	-5.19%	14.47%	-70.67%	-	-67.12%
Operating Cash Flow Growth	103.34%	146.16%	-6.01%	485.17%	-555.00%	-313.74%	-59.51%	-10.91%	-2,236.26%	-	-25.87%
Free Cash Flow Firm Growth	205.23%	104.73%	127.25%	-185.52%	-188.59%	-70.84%	-75.35%	100.52%	93.20%	-	56.53%
Invested Capital Growth	0.00%	-5.15%	-2.07%	0.00%	0.00%	-1.14%	2.41%	4.84%	7.53%	-	-1.85%
Revenue Q/Q Growth	-13.95%	43.31%	53.97%	0.00%	-37.64%	-36.84%	48.63%	59.71%	-47.35%	-	-24.35%
EBITDA Q/Q Growth	-46.72%	-110.68%	4,132.48%	0.00%	-36.67%	-85.40%	669.96%	73.47%	-80.70%	-	-29.54%
EBIT Q/Q Growth	-48.05%	-114.08%	3,259.46%	0.00%	-37.02%	-86.26%	719.21%	73.66%	-81.79%	-	-29.50%
NOPAT Q/Q Growth	-27.04%	-112.45%	3,327.95%	0.00%	-11.21%	-89.23%	862.77%	23.33%	-80.52%	-	-62.63%
Net Income Q/Q Growth	-17.68%	-91.70%	4,404.35%	0.00%	-0.54%	-82.26%	442.96%	20.52%	-74.42%	-	-60.31%
EPS Q/Q Growth	-16.00%	-90.48%	3,750.00%	0.00%	-1.32%	-82.67%	461.54%	19.18%	-74.71%	-	-58.62%
Operating Cash Flow Q/Q Growth	-97.81%	3,685.00%	384.35%	45.79%	-101.70%	-1,678.02%	191.75%	220.82%	-144.64%	-	-59.27%
Free Cash Flow Firm Q/Q Growth	0.99%	-94.82%	20.06%	0.00%	-4.62%	101.70%	1.50%	-71.18%	-1,464.40%	-	10.66%
Invested Capital Q/Q Growth	0.00%	0.00%	-1.88%	0.00%	3.88%	4.75%	1.63%	-5.20%	6.54%	-	-0.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	29.33%	13.82%	33.40%	34.69%	41.74%	30.68%	49.08%	44.78%	32.72%	-	40.02%
EBITDA Margin	12.37%	-0.92%	24.15%	26.40%	26.81%	6.20%	32.10%	34.87%	12.78%	-	19.79%
Operating Margin	11.87%	-1.17%	23.93%	26.15%	26.41%	5.74%	31.66%	34.43%	11.91%	-	19.23%
EBIT Margin	11.87%	-1.17%	23.93%	26.15%	26.41%	5.74%	31.66%	34.43%	11.91%	-	19.23%
Profit (Net Income) Margin	12.51%	0.73%	21.21%	21.29%	33.95%	9.53%	34.83%	26.28%	12.77%	-	11.33%
Tax Burden Percent	91.27%	80.70%	82.45%	77.07%	108.66%	85.15%	100.08%	71.07%	76.05%	-	49.06%
Interest Burden Percent	115.51%	-77.03%	107.49%	105.63%	118.32%	194.91%	109.92%	107.42%	141.02%	-	120.09%
Effective Tax Rate	8.73%	19.30%	17.55%	22.93%	-8.66%	14.85%	-0.08%	28.93%	23.95%	-	50.94%
Return on Invested Capital (ROIC)	0.00%	-0.46%	11.35%	29.63%	42.67%	3.17%	17.60%	14.14%	4.72%	-	5.58%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-1.63%	10.20%	28.55%	39.54%	2.02%	16.59%	13.42%	3.89%	-	5.12%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.27%	-2.24%	-9.42%	-12.66%	-0.51%	-4.62%	-4.66%	-1.26%	-	-1.74%
Return on Equity (ROE)	0.00%	-0.19%	9.10%	20.21%	30.01%	2.66%	12.98%	9.48%	3.45%	-	3.84%
Cash Return on Invested Capital (CROIC)	0.00%	7.89%	8.85%	-179.10%	-173.99%	14.04%	10.16%	9.30%	3.10%	-	11.96%
Operating Return on Assets (OROA)	0.00%	-0.45%	10.30%	12.39%	12.93%	2.69%	12.26%	12.47%	4.06%	-	7.30%
Return on Assets (ROA)	0.00%	0.28%	9.13%	10.09%	16.63%	4.47%	13.49%	9.52%	4.36%	-	4.30%
Return on Common Equity (ROCE)	0.00%	-0.19%	9.10%	20.21%	30.01%	2.66%	12.98%	9.48%	3.45%	-	3.84%
Return on Equity Simple (ROE_SIMPLE)	0.00%	2.46%	0.00%	7.70%	9.87%	10.29%	0.00%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	0.96	-0.12	3.86	3.85	3.42	0.37	3.54	4.37	0.85	2.78	1.04
NOPAT Margin	10.83%	-0.94%	19.73%	20.15%	28.69%	4.89%	31.69%	24.47%	9.05%	-	9.43%
Net Nonoperating Expense Percent (NNEP)	0.00%	1.17%	1.15%	1.07%	3.13%	1.15%	1.02%	0.73%	0.82%	-	0.45%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.10%	3.27%	-	2.73%	0.29%	2.72%	3.24%	0.63%	2.00%	0.74%
Cost of Revenue to Revenue	70.67%	86.18%	66.60%	65.31%	58.26%	69.32%	50.92%	55.22%	67.28%	-	59.98%
SG&A Expenses to Revenue	17.46%	14.98%	9.46%	8.54%	15.33%	24.93%	17.42%	10.35%	20.81%	-	20.79%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Operating Expenses to Revenue	17.46%	14.98%	9.46%	8.54%	15.33%	24.93%	17.42%	10.35%	20.81%	-	20.79%
Earnings before Interest and Taxes (EBIT)	1.05	-0.15	4.68	4.99	3.14	0.43	3.54	6.15	1.12	3.01	2.12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.10	-0.12	4.72	5.04	3.19	0.47	3.59	6.22	1.20	3.10	2.18
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.94	0.91	1.10	1.29	1.27	0.92	0.88	0.84	-	1.04
Price to Tangible Book Value (P/TBV)	0.00	0.94	0.91	1.10	1.29	1.27	0.92	0.88	0.84	-	1.04
Price to Revenue (P/Rev)	2.15	2.39	2.08	2.24	2.54	2.77	2.40	2.44	2.48	-	2.77
Price to Earnings (P/E)	4.70	38.44	15.98	14.31	13.03	12.38	9.38	8.85	10.85	-	14.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Earnings Yield	21.27%	2.60%	6.26%	6.99%	7.68%	8.08%	10.66%	11.30%	9.21%	-	7.04%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.94	0.87	1.15	1.42	1.39	0.88	0.81	0.76	-	1.06
Enterprise Value to Revenue (EV/Rev)	0.00	1.88	1.50	1.57	1.91	2.13	1.61	1.43	1.51	-	1.78
Enterprise Value to EBITDA (EV/EBITDA)	0.00	29.39	9.97	8.78	9.41	9.21	6.50	5.13	6.04	-	7.39
Enterprise Value to EBIT (EV/EBIT)	0.00	30.84	10.16	8.92	9.53	9.33	6.59	5.21	6.17	-	7.57
Enterprise Value to NOPAT (EV/NOPAT)	0.00	34.98	12.80	11.03	10.92	10.70	7.11	5.88	7.59	-	10.40
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	7.55	7.21	4.82	6.24	8.46	7.79	7.62	13.86	-	7.29
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	11.56	9.77	0.00	0.00	9.83	8.78	8.87	25.36	-	8.78
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Financial Leverage	0.00	-0.16	-0.22	-0.33	-0.32	-0.25	-0.28	-0.35	-0.32	-	-0.34
Leverage Ratio	0.00	1.05	1.04	1.04	1.03	1.03	1.03	1.04	1.03	-	1.03
Compound Leverage Factor	0.00	-0.81	1.12	1.10	1.22	2.02	1.14	1.12	1.45	-	1.24
Debt to Total Capital	0.00%	0.03%	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%	-	0.01%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Long-Term Debt to Total Capital	0.00%	0.03%	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%	-	0.01%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Common Equity to Total Capital	0.00%	99.97%	99.97%	99.97%	99.97%	99.98%	99.98%	99.98%	99.98%	-	99.99%
Debt to EBITDA	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Net Debt to EBITDA	0.00	-8.02	-3.83	-3.76	-3.12	-2.75	-3.21	-3.63	-3.89	-	-4.12
Long-Term Debt to EBITDA	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Debt to NOPAT	0.00	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Net Debt to NOPAT	0.00	-9.54	-4.91	-4.71	-3.62	-3.19	-3.52	-4.16	-4.88	-	-5.80
Long-Term Debt to NOPAT	0.00	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Altman Z-Score	0.00	14.55	15.80	19.18	26.57	34.90	21.14	14.35	18.97	-	24.13
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	17.63	20.17	20.96	26.03	34.79	28.12	19.27	27.73	-	29.60
Quick Ratio	0.00	4.46	6.26	8.41	10.09	12.59	10.42	8.29	10.93	-	13.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	92	4.77	5.73	-78	-82	1.39	1.41	0.41	-5.55	2.45	2.71
Operating Cash Flow to CapEx	42.11%	860.23%	5,022.60%	31,444.12%	-211.63%	-12,446.15%	679.41%	47,625.00%	-7,086.67%	-	73,366.67%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.39	0.43	0.47	0.49	0.47	0.39	0.36	0.34	-	0.38
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Inventory Turnover	0.00	0.00	0.56	0.71	0.68	0.57	0.46	0.44	0.41	-	0.47
Fixed Asset Turnover	0.00	0.00	3.91	4.61	4.87	4.30	3.62	3.35	3.13	-	3.40
Accounts Payable Turnover	0.00	6.28	7.69	9.61	12.71	9.51	7.10	5.35	7.26	-	8.05
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	650.98	515.42	533.39	646.00	799.23	823.86	889.00	-	774.05
Days Payable Outstanding (DPO)	0.00	58.12	47.47	37.99	28.71	38.39	51.39	68.17	50.28	-	45.33
Cash Conversion Cycle (CCC)	0.00	-58.12	603.51	477.43	504.68	607.61	747.84	755.68	838.73	-	728.72
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	90	88	82	85	89	91	86	91	89	89
Invested Capital Turnover	0.00	0.49	0.58	1.47	1.49	0.65	0.56	0.58	0.52	-	0.59
Increase / (Decrease) in Invested Capital	-91	-4.89	-1.87	82	85	-1.02	2.13	3.96	6.40	0.34	-1.67
Enterprise Value (EV)	0.00	84	77	94	121	124	80	69	69	-	94
Market Capitalization	88	107	107	135	161	161	119	118	114	-	146
Book Value per Share	$0.00	$21.59	$22.39	$23.11	$23.66	$23.83	$24.58	$25.39	$25.64	$26.27	$26.53
Tangible Book Value per Share	$0.00	$21.59	$22.39	$23.11	$23.66	$23.83	$24.58	$25.39	$25.64	$26.27	$26.53
Total Capital	0.00	114	118	122	125	126	130	135	136	139	141
Total Debt	0.00	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02
Total Long-Term Debt	0.00	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02
Net Debt	0.00	-23	-30	-40	-40	-37	-39	-49	-45	-50	-52
Capital Expenditures (CapEx)	0.10	0.18	0.15	0.03	0.09	0.03	0.44	0.02	0.06	0.02	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	63	61	55	59	62	63	59	65	62	63
Debt-free Net Working Capital (DFNWC)	0.00	86	91	96	99	99	103	108	109	112	115
Net Working Capital (NWC)	0.00	86	91	96	99	99	103	108	109	112	115
Net Nonoperating Expense (NNE)	-0.15	-0.21	-0.29	-0.22	-0.63	-0.35	-0.35	-0.32	-0.35	-0.36	-0.21
Net Nonoperating Obligations (NNO)	0.00	-24	-30	-40	-40	-37	-39	-49	-45	-50	-52
Total Depreciation and Amortization (D&A)	0.04	0.03	0.04	0.05	0.05	0.03	0.05	0.08	0.08	0.09	0.06
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	139.99%	119.26%	92.17%	93.92%	107.09%	127.34%	121.68%	140.39%	-	118.34%
Debt-free Net Working Capital to Revenue	0.00%	191.28%	177.07%	159.23%	157.32%	170.71%	206.75%	222.68%	237.50%	-	217.36%
Net Working Capital to Revenue	0.00%	191.28%	177.07%	159.23%	157.32%	170.71%	206.75%	222.68%	237.50%	-	217.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.02	$0.78	$0.77	$0.76	$0.13	$0.73	$0.88	$0.22	$0.59	$0.24
Adjusted Weighted Average Basic Shares Outstanding	0.00	5.30M	5.30M	5.31M	5.32M	5.32M	5.32M	5.33M	5.34M	5.34M	5.34M
Adjusted Diluted Earnings per Share	$0.00	$0.02	$0.77	$0.76	$0.75	$0.13	$0.73	$0.87	$0.22	$0.58	$0.24
Adjusted Weighted Average Diluted Shares Outstanding	0.00	5.35M	5.35M	5.35M	5.37M	5.38M	5.37M	5.38M	5.39M	5.39M	5.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	5.27M	5.29M	5.29M	5.29M	5.29M	5.31M	5.31M	5.31M	5.31M	5.32M
Normalized Net Operating Profit after Tax (NOPAT)	0.96	-0.12	3.86	3.85	2.20	0.37	2.48	4.37	0.85	2.78	1.48
Normalized NOPAT Margin	10.83%	-0.94%	19.73%	20.15%	18.48%	4.89%	22.16%	24.47%	9.05%	-	13.46%
Pre Tax Income Margin	13.71%	0.90%	25.73%	27.62%	31.24%	11.20%	34.80%	36.98%	16.79%	-	23.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%

Financials Breakdown Chart

Key Financial Trends

AMREP’s recent financial statements show a company with a strong balance sheet and consistently positive earnings, but with significant quarter-to-quarter volatility in revenue, profitability and operating cash flow.

AMREP remains profitable. Net income was positive in every reported quarter, increasing from $92,000 in Q3 2024 to $4.7 million in Q1 2026 before moderating to $1.2 million in Q4 2026. Earnings per share followed the same pattern, rising from $0.02 to a peak of $0.88 and ending at $0.24.
Long-term earnings have strengthened compared with early 2024. Quarterly operating income improved from a $148,000 loss in Q3 2024 to $2.1 million in Q4 2026, despite recent revenue fluctuations.
The company has generated substantial cash over the broader period. Operating cash flow was $9.5 million in Q1 2026 and $5.4 million in Q3 2026. Although cash flow was negative in Q2 2026, it rebounded to $2.2 million in Q4 2026.
Cash reserves have expanded materially. Cash increased from $21.8 million at the end of Q1 2024 to approximately $50.0 million at the latest reported balance-sheet date, Q3 2026.
AMREP carries very little debt. Long-term debt declined from $41,000 in Q1 2024 to $21,000 in Q3 2026. Financing cash outflows have primarily reflected small debt repayments rather than new borrowing.
Shareholders’ equity has grown steadily. Total equity increased from $112.4 million in Q1 2024 to $139.4 million in Q3 2026, supported by retained earnings and the company’s ongoing profitability.
Gross margins have generally improved from the 2024 trough. Gross margin was approximately 14% in Q3 2024, compared with roughly 40% in Q4 2026. However, margins remain uneven, ranging from about 33% in Q1 2026 to 41% in Q3 2026.
Capital spending remains limited. Quarterly purchases of property and equipment were generally modest, including only $3,000 in Q4 2026. This supports cash preservation but may also indicate limited investment in expansion.
Revenue has not established a consistent upward trend. Quarterly revenue declined from $19.1 million in Q1 2025 to $11.2 million in Q4 2025, rose to $17.9 million in Q1 2026, then fell to $9.4 million in Q2 and $11.0 million in Q4 2026. The pattern suggests meaningful operating or project timing volatility.
Operating cash flow has been inconsistent. AMREP reported operating cash outflows of $3.2 million in Q3 2025 and $4.3 million in Q2 2026, even while recording net income. The volatility was driven by changes in noncash items and operating assets and liabilities, making cash conversion an important area for investors to monitor.
Inventory remains a major balance-sheet concentration. Net inventory was approximately $66.8 million at the latest reported quarter, representing more than half of current assets. A slowdown in sales or delays in converting inventory to cash could pressure future liquidity.
Recent earnings momentum has weakened. Net income fell from $4.7 million in Q1 2026 to $1.2 million in Q4 2026, while diluted EPS declined from $0.87 to $0.24 over the same comparison. Q4 revenue and gross profit were also below Q1 levels.
Tax expense was unusually high in Q4 2026. Income tax expense of $1.3 million consumed approximately half of pretax income, compared with much lower effective tax rates in several prior quarters. If this level persists, it could limit future earnings growth.

Overall, AMREP’s financial position is a major strength: cash is high, debt is negligible and equity has grown. The primary risks are the company’s uneven revenue trajectory, inventory exposure and inconsistent conversion of accounting profits into operating cash flow. Investors should look for sustained revenue growth and several consecutive quarters of positive operating cash flow before concluding that the recent earnings improvement is durable.

07/25/26 04:29 PM ETAI Generated. May Contain Errors.

AMREP Financials - Frequently Asked Questions

According to the most recent income statement we have on file, AMREP's fiscal year ends in April. Their fiscal year 2026 ended on April 30, 2026.

AMREP's net income appears to be on an upward trend, with a most recent value of $10.29 million in 2026, falling from -$10.22 million in 2016. The previous period was $12.72 million in 2025. Check out AMREP's forecast to explore projected trends and price targets.

AMREP's total operating income in 2026 was $12.39 million, based on the following breakdown:

Total Gross Profit: $21.42 million
Total Operating Expenses: $9.03 million

Over the last 10 years, AMREP's total revenue changed from $41.66 million in 2016 to $52.85 million in 2026, a change of 26.8%.

AMREP's total liabilities were at $4.04 million at the end of 2026, a 5.8% increase from 2025, and a 89.3% decrease since 2016.

In the past 10 years, AMREP's cash and equivalents has ranged from $10.85 million in 2018 to $52.33 million in 2026, and is currently $52.33 million as of their latest financial filing in 2026.

Over the last 10 years, AMREP's book value per share changed from 10.28 in 2016 to 26.53 in 2026, a change of 158.1%.

Related Companies

Financial statements for NYSE:AXR last updated on 7/24/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AMREP (AXR) Financials

Financials Breakdown Chart

Key Financial Trends

AMREP Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AMREP (AXR) Financials

Annual Income Statements for AMREP

Quarterly Income Statements for AMREP

Annual Cash Flow Statements for AMREP

Quarterly Cash Flow Statements for AMREP

Annual Balance Sheets for AMREP

Quarterly Balance Sheets for AMREP

Annual Metrics And Ratios for AMREP

Quarterly Metrics And Ratios for AMREP

Financials Breakdown Chart

Key Financial Trends

AMREP Financials - Frequently Asked Questions

When does AMREP's financial year end?

How has AMREP's net income changed over the last 10 years?

What is AMREP's operating income?

How has AMREP's revenue changed over the last 10 years?

How much debt does AMREP have?

How much cash does AMREP have?

How has AMREP's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools